[Clinical trial of LD 4,644].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003872:Dermatitis / Q000188:drug therapy / Q000209:etiology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010689:Phlebitis / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use; D014647:Varicose Ulcer / Q000188:drug therapy; D014648:Varicose Veins / Q000150:complications
D000893:Anti-Inflammatory Agents; D010879:Piperazines; D010653:Phenylbutazone
Essai clinique du LD 4,644